Buy Day today: Neutral (53) Mixed market breadth · no major macro event

ANI Pharmaceuticals Inc (ANIP)

Healthcare Drug Manufacturers - Specialty & Generic

79.20 $

-1.5% vs. previous close

Closing price · As of: 31. Jul 2026

ANI Pharmaceuticals Inc (ANIP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 1,440 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow

Annual Quarterly

All figures in millions of USD.

Balance Sheet ANIP
Tick rows to compare them in a chart (up to 4)	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	264	285	323	412	431	457	461	772	760	904	1,284	1,440
Current Assets	203	193	103	132	153	188	170	322	344	520	528	753
Cash	169	155	27	31	43	62	7.9	100	48	221	145	286
Cash & Short-Term Investments	169	155	27	31	43	62	7.9	100	48	221	151	286
Receivables	17	22	46	59	65	72	96	129	165	162	222	281
Inventory	7.5	13	26	38	41	48	61	82	105	111	137	143
Property, Plant & Equipment	5.2	7.1	11	20	38	41	41	53	43	–	–	–
Goodwill	1.8	1.8	1.8	1.8	3.6	3.6	3.6	28	28	28	60	62
Intangible Assets	42	66	176	230	202	180	189	294	252	209	542	480
Total Liabilities	124	125	153	237	233	244	265	413	422	447	855	900
Current Liabilities	13	12	32	39	166	62	79	88	99	145	194	278
Short-Term Debt	107	113	121	3.4	116	9.9	13	0.9	0.9	0.9	9.2	17
Accounts Payable	2.7	2.1	3.4	3.6	8.9	15	11	23	29	37	46	63
Long-Term Debt	111	113	121	128	67	176	172	287	286	285	615	600
Shareholders' Equity	140	160	170	175	197	213	196	359	339	458	429	541
Retained Earnings	-20	-4.4	-2.9	-4.0	11	18	-5.0	-48	-97	-80	-100	-23
Shares Outstanding	11	12	12	12	12	12	12	13	16	18	19	21

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Cookie settings